Emis Group (LON:EMIS) was downgraded by stock analysts at Numis Securities to an “add” rating in a report released on Wednesday, Digital Look reports. They currently have a GBX 1,250 ($16.33) price target on the stock. Numis Securities’ price target would suggest a potential upside of 14.26% from the company’s previous close.

EMIS stock traded down GBX 14 ($0.18) during midday trading on Wednesday, hitting GBX 1,094 ($14.30). 33,278 shares of the stock traded hands, compared to its average volume of 171,465. The firm has a market cap of $689.45 million and a PE ratio of 30.39. Emis Group has a 1-year low of GBX 779 ($10.18) and a 1-year high of GBX 1,136 ($14.84).

Emis Group Company Profile

EMIS Group plc, through its subsidiaries, provides healthcare software, information technology, and related services for healthcare professionals in the United Kingdom. It operates in four segments: Primary, Community & Acute Care; Community Pharmacy; Specialist & Care; and Patient. The company offers clinical management systems that hold patient records for healthcare providers and commissioners; dispensary pharmacy management software for the community pharmacy market; and Egton non-clinical software for health and social care.

Further Reading: Swap

Receive News & Ratings for Emis Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Emis Group and related companies with MarketBeat.com's FREE daily email newsletter.